0000950123-22-009430.txt : 20220815 0000950123-22-009430.hdr.sgml : 20220815 20220815160247 ACCESSION NUMBER: 0000950123-22-009430 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220815 DATE AS OF CHANGE: 20220815 EFFECTIVENESS DATE: 20220815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bain Capital Life Sciences Investors, LLC CENTRAL INDEX KEY: 0001703031 IRS NUMBER: 813996001 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18477 FILM NUMBER: 221165596 BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6175162878 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001703031 XXXXXXXX 06-30-2022 06-30-2022 false Bain Capital Life Sciences Investors, LLC

200 Clarendon Street Boston MA 02116

13F HOLDINGS REPORT 028-18477 Y Bain Capital Life Sciences Investors, LLC is (i) the general partner of Bain Capital Life Sciences Partners, LP, which is the general partner of Bain Capital Life Sciences Fund, L.P., (ii) the general partner of BC SW, LP and (iii) the manager of Bain Capital Life Sciences Investors II, LLC, which is the general parter of Bain Capital Life Sciences Fund II, L.P. Bain Capital Life Sciences Investors, LLC governs the investment strategy and decision-making process with respect to investments held by BCIP Life Sciences Associates, LP.The shares of common stock of Savara Inc ("SVRA") included on the Information Table are as reported on Amendment No. 1 to the Schedule 13D filed by Bain Capital Life Sciences Fund II, L.P. and BCIP Life Sciences Associates, LP on March 17, 2021 and reflect the exercise of securities exercisable for shares of SVRA common stock held by such persons, after giving effect to the provisions of such securities that prevent the exercise of such securities if such persons would beneficially own more than 9.99% of the outstanding SVRA common stock following such exercise. As of June 30, 2022, such persons held an aggregate of 6,913,208 shares of SVRA common stock.The shares of common stock of Syros Pharmaceuticals, Inc. ("SYRS" ) included on the Information Table are as reported on Amendment No. 1 to the Schedule 13G filed by Bain Capital Life Sciences Fund II, L.P. and BCIP Life Sciences Associates, LP on February 14, 2022 and reflect the exercise of securities exercisable for shares of SYRS common stock held by such persons, after giving effect to the provisions of such securities that prevent the exercise of such securities if such persons would beneficially own more than 9.99% of the outstanding SYRS common stock following such exercise. As of June 30, 2022, such persons held an aggregate of 5,504,661 shares of SYRS common stock. Adam Koppel 617-516-2000 /s/ Adam Koppel Boston MA 08-15-2022 6 35 852695 false 1 28-18476 Bain Capital Life Sciences Partners, LP 2 28-18478 Bain Capital Life Sciences Fund, L.P. 3 28-20270 BC SW, LP 4 28-20816 Bain Capital Life Sciences Investors II, LLC 5 28-20814 Bain Capital Life Sciences Fund II, L.P. 6 28-21927 BCIP Life Sciences Associates, LP INFORMATION TABLE 2 16536.xml INFORMATION TABLE FOR FORM 13F 2SEVENTY BIO INC COMMON STOCK 901384107 18597 1408901 SH SOLE 1408901 0 0 ACADIA PHARMACEUTICALS INC COM 004225108 8461 600523 SH SOLE 600523 0 0 ADAGIO THERAPEUTICS INC COM 00534A102 6354 1937207 SH SOLE 1937207 0 0 AEGLEA BIOTHERAPEUTICS INC COM 00773J103 2701 5347689 SH SOLE 5347689 0 0 AMYLYX PHARMACEUTICALS INC COM 03237H101 37523 1948214 SH SOLE 1948214 0 0 ANNEXON INC COM 03589W102 12221 3241628 SH SOLE 3241628 0 0 APTINYX INC COM 03836N103 4961 8891758 SH SOLE 8891758 0 0 ARCUTIS BIOTHERAPEUTICS INC COM 03969K108 63930 3000000 SH SOLE 3000000 0 0 ARYA SCIENCES ACQU CORP IV CL A G31659108 6867 700000 SH SOLE 700000 0 0 ARYA SCIENCES ACQUISITN CORP CLASS A ORD SHS G31658100 4860 500000 SH SOLE 500000 0 0 ATEA PHARMACEUTICALS INC COM 04683R106 17648 2485638 SH SOLE 2485638 0 0 BCLS ACQUISITION CORP COM CL A G0904B105 4826 487500 SH SOLE 487500 0 0 C4 THERAPEUTICS INC COM STK 12529R107 12382 1642210 SH SOLE 1642210 0 0 CARA THERAPEUTICS INC COM 140755109 24171 2647473 SH SOLE 2647473 0 0 CRINETICS PHARMACEUTICALS IN COM 22663K107 42999 2305558 SH SOLE 2305558 0 0 DYNAVAX TECHNOLOGIES CORP COM NEW 268158201 105945 8415000 SH SOLE 8415000 0 0 EQRX INC COM 26886C107 46917 10003573 SH SOLE 10003573 0 0 FRAZIER LIFESCIENCES ACQU CO UNIT 12/09/2025 G3710A121 2961 300000 SH SOLE 300000 0 0 MARINUS PHARMACEUTICALS INC COM NEW 56854Q200 6926 1431058 SH SOLE 1431058 0 0 MERSANA THERAPEUTICS INC COM 59045L106 40026 8663673 SH SOLE 8663673 0 0 NAUTILUS BIOTECHNOLOGY INC COM 63909J108 5380 2000000 SH SOLE 2000000 0 0 NURIX THERAPEUTICS INC COM 67080M103 23096 1822883 SH SOLE 1822883 0 0 NUVALENT INC COM 670703107 46484 3428014 SH SOLE 3428014 0 0 PANACEA ACQUISITION CORP II CL A SHS G6882C106 4880 500000 SH SOLE 500000 0 0 PHARVARIS N V COM N69605108 70291 3180601 SH SOLE 3180601 0 0 PROTAGONIST THERAPEUTICS INC COM 74366E102 17881 2260572 SH SOLE 2260572 0 0 RAPID MICRO BIOSYSTEMS INC CLASS A COM 75340L104 36269 8434560 SH SOLE 8434560 0 0 RESEARCH ALLIANCE CORP II COM CL A 760873109 9800 1000000 SH SOLE 1000000 0 0 SAVARA INC COM 805111101 17666 11622598 SH SOLE 11622598 0 0 SOLID BIOSCIENCES INC COM 83422E105 4882 7929918 SH SOLE 7929918 0 0 SPRINGWORKS THERAPEUTICS INC COM 85205L107 118947 4831307 SH SOLE 4831307 0 0 SYROS PHARMACEUTICALS INC COM 87184Q107 6031 6264420 SH SOLE 6264420 0 0 TANGO THERAPEUTICS INC COM 87583X109 8706 1921790 SH SOLE 1921790 0 0 X4 PHARMACEUTICALS INC COM 98420X103 2914 3019540 SH SOLE 3019540 0 0 XILIO THERAPEUTICS INC COM 98422T100 8192 2805413 SH SOLE 2805413 0 0